Canagliflozin Attenuates Hepatic Steatosis and Atherosclerosis Progression in Western Diet-Fed ApoE-Knockout Mice

Canagliflozin Attenuates Hepatic Steatosis and Atherosclerosis Progression in Western Diet-Fed ApoE-Knockout Mice

Qingjuan Zuo,1,2 Guorui Zhang,1,3 Lili He,2 Sai Ma,4 Huijuan Ma,5 Jianlong Zhai,6 Zhongli Wang,7 Tingting Zhang,2 Yan Wang,2 Yifang Guo1,2 1Department of Internal Medicine, Hebei Medical University, Shijiazhuang, People’s Republic of China; 2Department of Geriatric Cardiology, Hebei General Hospital...

Full description

Bibliographic Details
Main Authors: Zuo Q, Zhang G, He L, Ma S, Ma H, Zhai J, Wang Z, Zhang T, Wang Y, Guo Y
Format: Article
Language:English
Published: Dove Medical Press 2022-12-01
Series:Drug Design, Development and Therapy
Subjects:
canagliflozin
hepatic steatosis
atherosclerosis
rna-seq
dyslipidemia
inflammatory response
autophagy
Online Access:https://www.dovepress.com/canagliflozin-attenuates-hepatic-steatosis-and-atherosclerosis-progres-peer-reviewed-fulltext-article-DDDT

Internet

https://www.dovepress.com/canagliflozin-attenuates-hepatic-steatosis-and-atherosclerosis-progres-peer-reviewed-fulltext-article-DDDT

Similar Items